Listed by the USPTO as AMICK, THOMAS RUSSE
Tech Center 1600 • Art Units: 1633 1638 1684
This examiner grants 74% of resolved cases
AMICK, THOMAS RUSSE is in tech center 1600 and art unit 1633. The profile records 107 resolved cases, a 73.8% allowance rate, and a 1436-day median time to allowance. The 29.4% interview lift is a positive association that makes interviews a relevant strategic option. The allowance result is favorable in the available record, but the median timing indicates that applicants should plan for an extended examination path.
The leading companies are The Ohio State University, The Regents of the University of California, and Sekisui Chemical Co., Ltd. The listed firms are Saul Ewing LLP (Philadelphia), BAKER BOTTS L.L.P., and BOZICEVIC, FIELD & FRANCIS LLP. Practitioners may prepare interviews to address defined issues, while maintaining written amendments and arguments that can support the application over the full timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18005936 | A CHEMICAL COCKTAIL DRIVING EXPANSION OF MYOGENIC STEM CELLS | Final Rejection | The Regents of the University of California |
| 18417617 | COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION | Non-Final OA | The United States Government as represented by the Department of Veterans Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy73.8% of resolved applications examined by Thomas Russe Amick were allowed (107 resolved cases), compared with 34.8% across Art Unit 1633 over the last five years.
This examiner's interview lift is +29.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Thomas Russe Amick took 1,436 days on average from filing to allowance.
Thomas Russe Amick examines applications in Art Unit 1633 in Tech Center 1600 (Biotechnology & Pharmaceuticals).